MedTrace Logo

Method Comparison and Clinical Specificity Study: Evaluation of the Infinium HD Cytogenetic Abnormality Test

NCT01426308 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 900

Last updated 2016-04-28

No results posted yet for this study

Summary

The study will determine the performance of the Infinium HD Test.

* The primary objective of the study is to assess the performance of the Infinium HD Test using banked DNA samples extracted from whole blood patient samples derived from the intended use population.
* The secondary objective of the study is to determine the background number of chromosomal abnormalities per person in the general population based on the resolution of the Infinium HD Test.

Conditions

  • Post-natal Cytogenetics

Sponsors & Collaborators

  • Illumina, Inc.

    lead INDUSTRY

Eligibility

Min Age
1 Minute
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2011-11-30
Completion
2011-11-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01426308 on ClinicalTrials.gov